News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Dainippon Sumitomo Pharma Co., Ltd. And ASKA Pharmaceutical To Dissolve Dealing Contract
January 26, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Tokyo, Jan 26, 2006 (JCN) - Dainippon Sumitomo Pharma and ASKA Pharmaceutical jointly announced on January 25 that they have agreed to dissolve their current dealing contract as o March 31, as requested by ASKA Pharmaceutical.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Europe
MORE ON THIS TOPIC
ALS
Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal
May 6, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans
May 6, 2025
·
2 min read
·
Tristan Manalac
Earnings
Vertex Shrugs Off Q1 Miss With ‘Strong’ Journavx Launch, Encouraging Pipeline Position
May 6, 2025
·
2 min read
·
Tristan Manalac
Layoffs
BMS Axes 516 More Employees in New Jersey
May 5, 2025
·
2 min read
·
Angela Gabriel